Members |
acceptabilityId |
rpT4b - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpT4c |
Preferred (foundation metadata concept) |
rpT4c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpT4d |
Preferred (foundation metadata concept) |
rpT4d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpT4e |
Preferred (foundation metadata concept) |
rpT4e - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpTX |
Preferred (foundation metadata concept) |
rpTX - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpTa |
Preferred (foundation metadata concept) |
rpTa - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpTis |
Preferred (foundation metadata concept) |
rpTis(DCIS) |
Preferred (foundation metadata concept) |
rpTis(DCIS)- Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpTis(LAMN) |
Preferred (foundation metadata concept) |
rpTis(LAMN)- Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpTis(Paget) |
Preferred (foundation metadata concept) |
rpTis(Paget) - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpTis- Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2023) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
rpm |
Preferred (foundation metadata concept) |
rt-PA - Tissue-type plasminogen activator |
Acceptable (foundation metadata concept) |
ry phenotype |
Preferred (foundation metadata concept) |
ry phenotype (finding) |
Preferred (foundation metadata concept) |
s |
Preferred (foundation metadata concept) |
s antigen |
Acceptable (foundation metadata concept) |
s+ phenotype |
Preferred (foundation metadata concept) |
s+ phenotype (finding) |
Preferred (foundation metadata concept) |
s- phenotype |
Preferred (foundation metadata concept) |
s- phenotype (finding) |
Preferred (foundation metadata concept) |
sC - Specific compliance |
Acceptable (foundation metadata concept) |
sFGR - selective fetal growth restriction |
Acceptable (foundation metadata concept) |
sFGR - selective foetal growth restriction |
Acceptable (foundation metadata concept) |
sIUGR - selective intrauterine growth restriction |
Acceptable (foundation metadata concept) |
scoops per day |
Acceptable (foundation metadata concept) |
scoops per meal |
Acceptable (foundation metadata concept) |
scoops/24h |
Preferred (foundation metadata concept) |
scoops/24h (qualifier value) |
Preferred (foundation metadata concept) |
scoops/day |
Preferred (foundation metadata concept) |
scoops/day (qualifier value) |
Preferred (foundation metadata concept) |
scoops/feed |
Preferred (foundation metadata concept) |
scoops/feed (qualifier value) |
Preferred (foundation metadata concept) |
scoops/meal |
Preferred (foundation metadata concept) |
scoops/meal (qualifier value) |
Preferred (foundation metadata concept) |
scyllo-Inosamine kinase |
Preferred (foundation metadata concept) |
scyllo-Inosamine kinase (substance) |
Preferred (foundation metadata concept) |
sdCHC - stomatin-deficient cryohydrocytosis |
Acceptable (foundation metadata concept) |
sec-Butyl acetate |
Preferred (foundation metadata concept) |
sec-Butyl acetate (substance) |
Preferred (foundation metadata concept) |
sec-Butyl acetate measurement |
Preferred (foundation metadata concept) |
sec-Butyl acetate measurement (procedure) |
Preferred (foundation metadata concept) |
sec-butanol |
Acceptable (foundation metadata concept) |
seconds of arc |
Preferred (foundation metadata concept) |
seconds of arc (qualifier value) |
Preferred (foundation metadata concept) |
sex linked Lu(a-b-) phenotype |
Acceptable (foundation metadata concept) |
siRNA - Small interfering RNA |
Acceptable (foundation metadata concept) |
sn-Glycerol-3-phosphate 1-galactosyltransferase |
Preferred (foundation metadata concept) |
sn-Glycerol-3-phosphate 1-galactosyltransferase (substance) |
Preferred (foundation metadata concept) |
sn-Glycerol-3-phosphate 2-alpha-galactosyltransferase |
Preferred (foundation metadata concept) |
sn-Glycerol-3-phosphate 2-alpha-galactosyltransferase (substance) |
Preferred (foundation metadata concept) |
snRNP |
Acceptable (foundation metadata concept) |
snRNP - Small nuclear ribonucleoprotein antibody |
Acceptable (foundation metadata concept) |
sq. cm |
Preferred (foundation metadata concept) |
sq. ft |
Preferred (foundation metadata concept) |
sq. in |
Preferred (foundation metadata concept) |
sq. m |
Preferred (foundation metadata concept) |
sq. mm |
Preferred (foundation metadata concept) |
sq. yd |
Preferred (foundation metadata concept) |
square centimetre |
Acceptable (foundation metadata concept) |
square centimetres |
Acceptable (foundation metadata concept) |
square decimetre |
Acceptable (foundation metadata concept) |
square metre |
Acceptable (foundation metadata concept) |
square metres |
Acceptable (foundation metadata concept) |
square millimetre |
Acceptable (foundation metadata concept) |
square millimetres |
Acceptable (foundation metadata concept) |
ssDNA - Single-stranded deoxyribonucleoprotein antibody |
Acceptable (foundation metadata concept) |
ssDNA binding autoantibody level |
Preferred (foundation metadata concept) |
ssDNA binding autoantibody level |
Preferred (foundation metadata concept) |
ssDNA binding autoantibody level (procedure) |
Preferred (foundation metadata concept) |
ssDNA binding autoantibody level (procedure) |
Preferred (foundation metadata concept) |
ssRNA phage virus |
Acceptable (foundation metadata concept) |
stat |
Acceptable (foundation metadata concept) |
stones - unit |
Preferred (foundation metadata concept) |
stones - unit (qualifier value) |
Preferred (foundation metadata concept) |
sym-Norspermidine synthase |
Preferred (foundation metadata concept) |
sym-Norspermidine synthase (substance) |
Preferred (foundation metadata concept) |
t |
Preferred (foundation metadata concept) |
t1 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t10 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t11 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t12 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t14 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t16 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t17 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t18 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t19 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t2 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t20 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t201 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t208 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t21 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |
t210 specific IgE antibody measurement |
Acceptable (foundation metadata concept) |